Cytokine-induced expression of ICAM-1 (Intercellular Adhesion Molecule-1, CD54) on the surface of epidermal keratinocytes is a prerequisite for leukocyte/keratinocyte attachment and immunologic cytotoxicity of keratinocytes. We have found that the epidermis is a stratified immunologic environment, especially with respect to ICAM-1 induction. We propose that the epidermal basal keratinocyte is particularly susceptible to immunologic cytotoxicity because of enhanced ICAM-1 induction by cytokines. In this grant we will focus on individual and differentiation-dependent variation in induction of ICAM-1 expression in keratinocytes. We will identify """"""""high"""""""" and """"""""low"""""""" responders to TNF-a and IFN-g by analysis of cell surface ICAM-1 expression and distribution by FACS and ELISA. We will determine if cultured keratinocytes from these donors show significant differences in cytokine receptor distribution, density or function, and whether these receptors can be induced by cytokine priming. We will also analyze the effects of keratinocyte differentiation on these receptor variables and on ICAM-1 MRNA induction using Northern and slot blot analysis. Individual and differentiation-dependent differences in release of TNF-a in keratinocytes will also be characterized by FACS, immunoblot and Northern blot analysis, to further characterize the high TNF-a responder phenotype. We will also determine if IL-1a is an inducer of ICAM-1 in basal keratinocytes and whether icIL-1ra is responsible for low IL-l responses in more differentiated keratinocytes. Finally, we will verify that enhanced ICAM-1 expression determines the level of immunologic cytotoxicity of keratinocyte targets. We will further test this hypothesis in a prototype of basal keratinocyte cytotoxicity: photosensitive lupus erythematosus. Using keratinocytes from lupus patients, we propose to show that TNF-a induction of expression of ICAM-1 and Ro/SSA or La/SSB antigens on the cell surface of keratinocytes renders these cells susceptible to cytotoxic damage by anti Ro/SSA or La/SSA antibodies and/or cellular effectors. These experiments address the control and functional significance of the stratified expression of the adhesion molecule ICAM-1 in the epidermis-a most critical step in keratinocyte cytotoxicity. This work is crucial in our long-term study of the cytotoxic mechanisms of skin diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
2R01AR026427-12A1
Application #
3155407
Study Section
General Medicine A Subcommittee 2 (GMA)
Project Start
1980-01-01
Project End
1996-06-30
Budget Start
1992-07-31
Budget End
1993-06-30
Support Year
12
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Colorado Denver
Department
Type
Schools of Medicine
DUNS #
065391526
City
Aurora
State
CO
Country
United States
Zip Code
80045
Reuland, Steven N; Smith, Shilo M; Bemis, Lynne T et al. (2013) MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD). J Invest Dermatol 133:1286-93
Reuland, Steven N; Goldstein, Nathaniel B; Partyka, Katie A et al. (2012) ABT-737 synergizes with Bortezomib to kill melanoma cells. Biol Open 1:92-100
Reuland, Steven N; Goldstein, Nathaniel B; Partyka, Katie A et al. (2011) The combination of BH3-mimetic ABT-737 with the alkylating agent temozolomide induces strong synergistic killing of melanoma cells independent of p53. PLoS One 6:e24294
Smith, Shilo M; Wunder, Michael B; Norris, David A et al. (2011) A simple protocol for using a LDH-based cytotoxicity assay to assess the effects of death and growth inhibition at the same time. PLoS One 6:e26908
Goldstein, Nathaniel B; Johannes, Widya U; Gadeliya, Agnessa V et al. (2009) Active N-Ras and B-Raf inhibit anoikis by downregulating Bim expression in melanocytic cells. J Invest Dermatol 129:432-7
Miller, Leslie A; Goldstein, Nathaniel B; Johannes, Widya U et al. (2009) BH3 mimetic ABT-737 and a proteasome inhibitor synergistically kill melanomas through Noxa-dependent apoptosis. J Invest Dermatol 129:964-71
Shellman, Yiqun G; Howe, William R; Miller, Leslie A et al. (2008) Hyperthermia induces endoplasmic reticulum-mediated apoptosis in melanoma and non-melanoma skin cancer cells. J Invest Dermatol 128:949-56
Ruth, Mariah C; Xu, Yisheng; Maxwell, Ian H et al. (2006) RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway. J Invest Dermatol 126:862-8
Shellman, Yiqun G; Makela, Marja; Norris, David A (2006) Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines. Melanoma Res 16:207-11
Ribble, Deborah; Goldstein, Nathaniel B; Norris, David A et al. (2005) A simple technique for quantifying apoptosis in 96-well plates. BMC Biotechnol 5:12

Showing the most recent 10 out of 40 publications